Related Experiment Video
Updated: May 27, 2025

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Perceived HBV-Related Stigma Is Associated With Lower Antiviral Medication Adherence in Patients With Chronic
Hee-Soon Juon1, Daniel Yang1, Cindy Xin Fang1
1Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Insights
Medication adherence in Korean Americans with chronic hepatitis B (CHB) is influenced by age, knowledge of CHB, and perceived stigma. Improving adherence requires addressing personal and healthcare factors for better liver disease management.
Area of Science:
- Hepatology
- Public Health
- Behavioral Science
Background:
- Medication nonadherence in chronic hepatitis B (CHB) patients can accelerate liver disease progression to cirrhosis and hepatocellular carcinoma (HCC).
- Understanding adherence factors in high-risk ethnic groups, such as Korean Americans, is crucial for effective management.
Purpose of the Study:
- To investigate the psychosocial and clinical factors influencing medication adherence in Korean American patients with CHB.
- To identify specific determinants of adherence to antiviral therapy in this population.
Main Methods:
- A cohort of 365 Korean American CHB patients from Philadelphia and Los Angeles was surveyed.
- The 8-item Morisky Medication Adherence Scale (MMAS-8) assessed adherence to antiviral medications.
- Descriptive and multivariable logistic regression analyses identified factors associated with MMAS-8 scores.
Main Results:
- 78% of participants received antiviral therapy, with 69% showing medium to high adherence.
- Older age, greater knowledge of CHB sequelae, lower perceived HBV stigma, and having a pharmacy plan were linked to higher medication adherence.
- Younger age, less knowledge, higher stigma, and lack of pharmacy plans were associated with lower adherence.
Conclusions:
- Personal factors like knowledge of CHB and perceived stigma, alongside healthcare factors such as pharmacy plans, significantly impact medication adherence.
- Targeted educational interventions focusing on these personal factors are recommended to improve adherence among Korean American CHB patients.
Abstract:
Medication nonadherence among patients with chronic hepatitis B (CHB) can lead to severe liver disease progression, including liver cirrhosis and hepatocellular carcinoma (HCC). Yet the factors that influence adherence in high-risk groups, like Korean Americans, remain unclear. Thus, this study explored the psychosocial and clinical factors affecting medication adherence in CHB patients. A cohort of 365 Korean American patients with CHB from two clinics in Philadelphia and Los Angeles was studied. The 8-item Morisky Medication Adherence Scale (MMAS-8) gauged their adherence to antiviral medication. Using descriptive and multivariable logistic regression analyses, we identified factors associated with MMAS-8 scores. Of the participants, 78% were undergoing antiviral therapy, with over two-thirds (69%) reporting medium to high adherence levels. The multivariable logistic regression analysis revealed that age, knowledge of sequalae of CHB, perceived HBV stigma and possession of pharmacy plan were associated with medication adherence. Older participants had higher medication adherence than younger. High knowledge of sequalae of CHB and low perceived HBV stigma were associated with higher medication adherence. Having pharmacy plans was also associated with higher medication adherence to antiviral therapy. These findings highlight the critical role of person-related factors (e.g., knowledge and stigma) and healthcare factors in medication adherence. Future research should focus on developing targeted educational interventions focusing on personal factors to improve medication adherence among Korean American patients with CHB.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
11:28Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
Published on: March 13, 2015
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Drug Therapy
Antianxiety Medications
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...